# US 2016/0355875 A1 · Methods and kits for detecting nucleic acid sequences of interest using dna-binding protein domain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355875 A1
- Document ID: US20160355875A1
- Status: Published application
- Kind: A1
- Application number: 15/028,644
- Filed: 2014-10-10
- Published: 2016-12-08
- Earliest claimed: 2013-10-11
- Assignees: Cellectis
- Applicants: Cellectis
- Inventors: Julien VALTON; Alexandre JUILLERAT; Fayza DABOUSSI; Marine BEURDELEY; Claudia BERTONATI; Philippe DUCHATEAU
- Web page: https://patentgrep.com/patent/US20160355875A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6841: In situ hybridisation
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for the detection of a specific nucleic acid. Specifically, the invention provides a method and kits for detecting the presence of a specific nucleic acid using engineered DNA-binding domains such as Transcription Activator Like-Effector (TALE) domain or modular base-per-base binding domains (MBBBD). The method of the invention is particularly useful for in vitro diagnostic application.

## Claims

### Claim 1

A method of detecting a nucleic acid sequence of interest comprising:
(a) Providing nucleic acids which can comprise the nucleic acid sequence of interest;
(b) Providing at least one DNA binding domain capable of binding said nucleic acid sequence of interest;
(c) Contacting said nucleic acids with said DNA binding domain;
(d) Removing unbound said DNA binding domain and nucleic acids and;
(e) Detecting the presence or the absence of the nucleic acid sequence of interest.

### Claim 2 (depends on 1)

The method of claim 1 further comprising quantifying said nucleic acid of interest.

### Claim 3 (depends on 1)

The method of claim 1 for detecting a single strand nucleic acid of interest (pray) comprising: providing a nucleic acid sequence (bait) comprising a complementary sequence to a part of said pray sequence; hybridizing said pray and bait sequences such that said DNA binding domain can bind the hybridized pray: bait sequence.

### Claim 4 (depends on 1)

The method according to claim 1 for detecting a specific nucleic acid wherein said nucleic acid is a DNA, RNA or DNA/RNA heteroduplex.

### Claim 5 (depends on 1)

The method according to claim 1 wherein said DNA binding domain is derived from a TALE or MBBBD protein.

### Claim 6 (depends on 1)

The method of detecting a nucleic acid sequence according to claim 1, wherein said nucleic acids are in a biological sample.

### Claim 7 (depends on 1)

The method according to claim 1 wherein said nucleic acids are within a cell.

### Claim 8 (depends on 1)

The method according to claim 1 wherein the DNA binding domain is fused to a reporter molecule.

### Claim 9 (depends on 8)

The method of claim 8 wherein the reporter molecule is selected from the group consisting of: fluorescent protein, chemiluminescent molecule, tag and enzyme.

### Claim 10 (depends on 3)

The method according to claim 3 wherein the bait sequence is labeled.

### Claim 11 (depends on 3)

The method according to claim 3 wherein the DNA-binding domain and/or said bait sequence are immobilized on a solid support.

### Claim 12

A kit comprising a DNA binding domain specific to a nucleic acid sequence of interest to detect.

### Claim 13 (depends on 12)

The kit of claim 12 wherein said DNA binding domain is fused to a reporter molecule.

### Claim 14 (depends on 12)

A diagnostic kit of claim 12 comprising a DNA binding domain specific to a genetic abnormality in a subject.

### Claim 15 (depends on 12)

A diagnostic kit of claim 12 comprising a DNA binding domain specific to a nucleic acid sequence comprising a single nucleotide polymorphism present in a subject.

### Claim 16 (depends on 12)

A diagnostic kit of claim 12 comprising a DNA binding domain specific to a nucleic acid sequence comprising a unique marker for a specific type of cancer.
